Potency and safety analysis of hemp-derived delta-9 products: The hemp vs. cannabis demarcation problem
Posted on November 28, 2023 By LabLynx Journal articles
Contents
Tools
Actions
General
- What links here
- Related changes
- Upload file
- Special pages
- Permanent link
- Page information
- Cite this page
- Get shortened URL
- Download QR code
Print/export
- Download as PDF
- Printable version
In other projects
- Wikidata item
Appearance
Pharmaceutical drug classification
ATC code A: Alimentary tract and metabolism |
---|
|
Other ATC codes |
ATC code A Alimentary tract and metabolism is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code A". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QA". WHO Collaborating Centre for Drug Statistics Methodology.
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System | |
---|---|
gastrointestinal tract / metabolism (A) | |
blood and blood forming organs (B) | |
cardiovascular system (C) | |
skin (D) | |
genitourinary system (G) | |
endocrine system (H) | |
infections and infestations (J, P, QI) | |
malignant disease (L01–L02) | |
immune disease (L03–L04) | |
muscles, bones, and joints (M) | |
brain and nervous system (N) |
|
respiratory system (R) | |
sensory organs (S) | |
other ATC (V) | |
Magnesium (increases motility) | |
---|---|
Aluminium (decreases motility) | |
Calcium | |
Sodium | |
Combinations and complexes of aluminium, calcium and magnesium |
H2 antagonists ("-tidine") | |
---|---|
Prostaglandins (E)/ analogues ("-prost-") | |
Proton-pump inhibitors ("-prazole") | |
Potassium-competitive acid blockers ("-prazan") | |
Others | |
Combinations | |
|
Drugs for functional gastrointestinal disorders (A03) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drugs for functional bowel disorders |
| ||||||||||||
Belladonna and derivatives (antimuscarinics) |
| ||||||||||||
Propulsives |
Stool softeners | |
---|---|
Stimulant laxatives | |
Bulk-forming laxatives | |
Lubricant laxatives | |
Osmotic laxatives | |
Enemas | |
Opioid antagonists | |
Others |
Rehydration | |
---|---|
Intestinal anti-infectives | |
Intestinal adsorbents |
|
Antipropulsives (opioids) |
|
Intestinal anti-inflammatory agents |
|
Antidiarrheal micro-organisms | |
Other antidiarrheals | |
|
| |||||||||||||||||||||||||||||||||||||||||||
|
Fat soluble |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Water soluble |
| ||||||||
Combinations | |||||||||
|
Major |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trace |
| ||||||||||||
Ultratrace |
| ||||||||||||
|
Androgens (incl. AASTooltip anabolic–androgenic steroid) |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antiandrogens |
| ||||||||||||
|
Amino acids and derivatives | |
---|---|
Enzymes |
|
Other |
by LabLynx